92 results
8-K
EX-99.1
AGIO
Agios Pharmaceuticals Inc
15 Feb 24
Agios Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
7:03am
from the third quarter of 2023, primarily driven by lower customer inventory levels at the end of the fourth quarter of 2023, partially offset … agreement with Alnylam, partially offset by a reduction in expenses associated with the evolution of our research organization and the sale of our
8-K
EX-99.2
AGIO
Agios Pharmaceuticals Inc
8 Jan 24
Agios Announces Key Anticipated 2024 Milestones Across Rare Disease Portfolio
7:58am
variable. The natural log of time on study was used as the offset to account for the varying lengths of subjects’ time in the Double-blind Period
8-K
EX-99.1
xema48
3 Nov 22
Agios Reports Business Highlights and Third Quarter 2022 Financial Results
7:02am
8-K
EX-10.1
dmm49of bjetxfg
7 Oct 22
Departure of Directors or Certain Officers
4:05pm
8-K
EX-99.1
98m1mcwwqhx
5 May 22
Agios Reports Business Highlights and First Quarter 2022 Financial Results
7:21am
8-K
EX-99.1
g481 bmmp
24 Feb 22
Agios Reports Fourth Quarter and Full Year 2021 Financial Results
7:40am